Log in / Register Soon
Official Education Partner of the Delhi Medicos Premier League — free question bank for every player and college
Q3 LONG ANSWER 10M ★ High-yield

Describe Corynebacterium diphtheriae with its morphology, toxin, clinical features, laboratory diagnosis and prevention.

Microbiology · 2nd Professional — Para-Clinical

Morphology and Cultural Characteristics

  • Gram-positive, non-motile, non-sporing, non-capsulated bacilli that are club-shaped (swollen at one end) and markedly pleomorphic
  • Arranged at angles in "chinese letter" or cuneiform patterns, because the cells snap after division rather than separating cleanly
  • Metachromatic granules (volutin, Babes-Ernst granules) of polymetaphosphate are demonstrated by ALBERT stain, appearing bluish-black against a green bacillus, and by Neisser and Ponder stains
MediumPurpose
Loeffler serum slopeAn enriched medium giving very rapid growth in 6 to 8 hours, well before other organisms — and it best demonstrates the granules and morphology
Potassium tellurite blood agarSelective — tellurite inhibits other throat flora; the organism reduces tellurite and forms characteristic black or grey colonies
Blood agarTo exclude streptococcal infection
Biotypes on telluriteGravis (large grey, "daisy head", most often epidemic and toxigenic), intermedius (small, most virulent), mitis (black, glossy, least virulent)

Diphtheria Toxin

The tox gene is carried by a bacteriophage, not by the bacterium — lysogenic conversion by beta-phage → Toxin production requires a low iron concentration in the medium and in tissue → The toxin has two fragments — B binds the cell surface receptor and A is the active enzyme → Fragment A catalyses ADP-ribosylation of elongation factor 2 (EF-2) → protein synthesis stops in the affected cell → A single molecule can inactivate all the EF-2 in a cell, so the toxin is extraordinarily potent → Local necrosis produces the pseudomembrane; absorbed toxin damages heart, nerves and kidney

CLINICAL PEARL

Corynebacterium diphtheriae is harmless unless a virus has infected it first. The gene for the toxin is carried by the beta-phage, so a non-lysogenised strain colonises the throat without causing disease. This is why toxigenicity must be tested, not assumed — and it is the reason a non-toxigenic isolate needs no antitoxin. Virulence here is borrowed rather than intrinsic.

Clinical Features

  • Faucial diphtheria is commonest — a tough, adherent, greyish-white pseudomembrane over the tonsils and pharynx, which bleeds when removed (unlike a candidal or streptococcal exudate). It consists of fibrin, necrotic epithelium, leucocytes and organisms
  • "bull neck" from marked cervical lymphadenopathy and oedema, with severe toxaemia disproportionate to the modest fever
  • Laryngeal diphtheria — hoarseness, stridor and respiratory obstruction from membrane extension, which may require tracheostomy; a particular danger in young children
  • Other sites — nasal (often mild and a source of carriage), cutaneous (common in tropical countries and an important reservoir), conjunctival, genital
  • Complications from absorbed toxin — myocarditis in the second week (arrhythmia, heart block, cardiac failure — the commonest cause of death); palatal palsy with nasal regurgitation and a nasal voice around the third week; and later polyneuritis including ocular and diaphragmatic paralysis; acute tubular necrosis

Laboratory Diagnosis and Tests for Toxigenicity

  • Swabs from the edge of and beneath the membrane, and from the nose
  • Direct smear — Albert stain for granules and Gram stain; suggestive but not confirmatory, since diphtheroids are normal throat flora
  • Culture — Loeffler slope (rapid), tellurite (selective) and blood agar, examined at 6 to 8 hours and again at 24 to 48 hours
  • ELEK test — an in-vitro immunoprecipitation test: a filter paper strip soaked in antitoxin is laid on the agar and the strain streaked at right angles; arrowhead lines of precipitation where toxin meets antitoxin indicate toxigenicity
  • PCR for the tox gene — rapid, though it detects the gene rather than its expression
  • In-vivo tests (guinea-pig inoculation, intradermal test) are of historical interest only
  • SCHICK test — a historical intradermal test of susceptibility, measuring circulating antitoxin; now replaced by serology and no longer performed

Other Corynebacteria and Differential Diagnosis

ConsiderationDetail
DiphtheroidsNon-pathogenic corynebacteria (C. Xerosis, C. Hofmannii) are normal flora of skin, throat and conjunctiva — so isolating a corynebacterium from a throat swab means nothing until toxigenicity is established
C. UlceransMay also carry the tox gene and cause a diphtheria-like illness; acquired from cattle and raw milk
C. JeikeiumMultidrug-resistant; causes line and prosthetic infection in the immunocompromised
C. MinutissimumErythrasma — coral-red fluorescence under Wood light
Membranous pharyngitis — differentialStreptococcal tonsillitis (exudate wipes off easily, no bleeding); infectious mononucleosis (with lymphadenopathy and atypical lymphocytes); Vincent angina (fusospirochaetal, foul odour, ulcerative); candidiasis; agranulocytosis

Treatment, Prevention and Applied Aspects

  • Antitoxin is given immediately on clinical suspicion, without waiting for laboratory confirmation, because it neutralises only circulating toxin — once the toxin has bound to tissue the damage cannot be reversed. Delay of even a day increases mortality substantially. A test dose is given, since it is horse serum
  • Antibiotics (penicillin or erythromycin) eliminate the organism and stop further toxin production and transmission, but they do not substitute for antitoxin
  • Supportive care — strict bed rest for weeks because of myocarditis, cardiac monitoring, airway management with tracheostomy if needed, and isolation until two negative cultures
  • Prevention by toxoid — formalin-treated toxin that is immunogenic but non-toxic, given as DPT or pentavalent vaccine in India's Universal Immunisation Programme, with boosters. Immunity wanes, so adult boosters matter — the resurgence of diphtheria in the former Soviet Union followed a fall in adult immunity
  • Contacts — culture, antibiotic prophylaxis, and a booster dose
  • Diphtheria persists in parts of India in older children and adults with waning immunity and in under-vaccinated pockets, so it must remain in the differential of membranous pharyngitis; the diagnosis is clinical and treatment cannot wait
  • Do not attempt to remove the membrane; it bleeds and increases toxin absorption, and may obstruct the airway
  • Nurse the patient with strict bed rest for 2 to 3 weeks and monitor the electrocardiogram; myocarditis appears in the second week, when the throat is improving and the patient feels well enough to move about
  • Cutaneous diphtheria is an important and neglected reservoir in tropical countries, maintaining transmission silently in communities where faucial disease is rare
  • Immunisation does not prevent carriage, only disease — so a vaccinated population can still transmit, which is why outbreak control requires contact tracing and prophylaxis rather than vaccination alone
  • Send swabs before starting antibiotics, but never delay antitoxin for the result; the laboratory confirms the diagnosis, it does not make it
  • Antitoxin is horse serum, so a test dose is given and adrenaline kept ready; serum sickness may follow a week later, and neither risk justifies withholding it in suspected diphtheria
  • Notify the case and investigate the contacts; diphtheria is a notifiable disease and a single case indicates a gap in immunisation coverage in that community
  • Check and complete immunisation in every child presenting with any illness; opportunistic vaccination catches those missed by the routine schedule, and diphtheria is a disease of the unimmunised
  • Isolate the patient until two consecutive negative cultures taken at least 24 hours apart and after antibiotics have finished
  • Give a booster to close contacts as well as prophylaxis, since their immunity is likely to have waned in the same way as the index case's
  • Toxoid is one of the oldest and most effective vaccines in use, and the near-disappearance of diphtheria from well-vaccinated populations is among the clearest demonstrations of what immunisation achieves
  • Low iron promotes toxin production, which is a curious detail with a practical corollary: the organism is most dangerous in exactly the iron-poor conditions found at a mucosal surface
  • Diphtheria antitoxin supply is limited worldwide, and delays in obtaining it contribute to mortality; hospitals in endemic areas should know where their nearest supply is held before they need it
  • The Elek test remains the standard toxigenicity test in many laboratories, and its result determines whether contacts need prophylaxis and whether the case is notifiable as diphtheria
  • Consider diphtheria in an unimmunised adult with a sore throat and disproportionate toxaemia, particularly with cervical swelling; the low fever is deceptive and delays the diagnosis
  • Laryngeal obstruction may develop rapidly in a small child, so the airway must be assessed repeatedly and tracheostomy facilities kept available

All questions in Gram-positive Cocci & Bacilli

  1. Q1Classify staphylococci. Describe the virulence factors, toxin-mediated diseases and laboratory diagnosis of Staphylococcus aureus. ★
  2. Q2Classify streptococci. Describe the virulence factors, diseases and non-suppurative sequelae of Streptococcus pyogenes. ★
  3. Q3Describe Corynebacterium diphtheriae with its morphology, toxin, clinical features, laboratory diagnosis and prevention. ★
  4. Q4Describe Clostridium tetani and Clostridium perfringens with their toxins, clinical features and management. ★
  5. Q5Describe Bacillus anthracis with its morphology, toxin, clinical forms and diagnosis. Add a note on other aerobic spore-bearers. ★
  6. SN1Describe Streptococcus pneumoniae with its identification, diseases and prevention. ★
  7. SN2Describe MRSA with its mechanism of resistance, detection, treatment and control. ★
  8. SN3Describe Clostridium botulinum and botulism with its clinical forms and management. ★
  9. SN4Describe Clostridioides difficile infection with its pathogenesis, diagnosis and management. ★
  10. SN5Describe the enterococci with their intrinsic resistance, infections and VRE. ★
  11. SN6Describe Listeria monocytogenes with its pathogenesis, clinical disease and treatment. ★
  12. SN7Compare Actinomyces and Nocardia. Add a note on mycetoma.

Every Microbiology chapter →

Scroll to Top